Wandercraft completes acquisition of Ekso Bionics operating business - 2026-10-01 - Acquisition - Atalante X and EksoNR together support patients at more than 700 rehabilitation centers worldwide. Wandercraft intends to keep supporting Atalante X, EksoNR, Eve and Indego Personal. Both boards unanimously approved the… - source: wandercraft.eu
Wandercraft commercially launches Eve exoskeleton in the U.S. - 2026-09-17 - Product Launch - Eve is the first FDA-cleared personal exoskeleton without restrictions based on the neurological level of spinal cord injury, extending eligibility beyond previously cleared devices. National Seating & Mobility, Wandercraft's… - source: globenewswire.com
Wandercraft receives FDA clearance for Eve personal exoskeleton - 2026-08-11 - Regulatory - Eve is intended for level indoor surfaces and level surfaces in immediately adjacent open-air areas such as patios and terraces, under the supervision of a specially trained companion. The clearance builds on Atalante X… - source: wandercraft.eu